Diabetic foot: barriers to care and prevention


#1

In the last two decades interest has grown in a forgotten complication of diabetes: diabetic foot syndrome. The evidence base for clinical practice is improving, as shown by the publication of the new edition of the International Guidelines of the International Working Group on the Diabetic Foot (IWGDF) to be presented next month at the 7th International Symposium on the Diabetic Foot. Additionally, the IDF Task Force on Diabetic Foot and the IWGDF work together on implementation of the ‘Train the Foot Trainer’ course on how to set up diabetic foot care.

As it is a right to receive insulin and other essential medications, it can be said that a person with diabetes has the right to receive appropriate foot care without extensive delay. But what diabetic foot care is essential for each person with diabetes? Should every person with diabetes have access to a yearly foot screening and adjusted shoes? Furthermore, numerous barriers still exist in implementation of foot care in both low- and high-resource settings. The barriers can be divided in three categories:

Availability of health care resources;
Patient-related factors;
Factors related to health care systems.

As written by William Van Houtem in 2012: “The opening for improvement in diabetic foot care should be aimed for and any barriers made visible, allowing for change and perfection to occur.”

Let us discuss the barriers and improve our knowledge, skills and daily care.
Is diabetic foot care available in your country and what are the barriers for implementation of this care?


#2

It is a lovely sunny day in London and I do not want to be too provocative.

However, I feel that we must consider the following questions

Q Why are patients coming to major amputation?

A Because of severe tissue loss.

Q Why are they having such extensive tissue loss?

A Because of infection, predisposed in some cases by ischaemia but it is comparatively rare for ischaemia itself to cause extensive tissue destruction.

Q Why is infection allowed to cause such extensive tissue loss

A 1. Late presentation by the patient.

2 Difficulties in diagnosis of infection

  1. Difficulties in treatment of infection

At present the management of diabetic foot infection is not a success


#3

This article is interesting. I was struck by the termLate Presentation by the Patient, which is a common practice. Let’s warn them then.

Here is a a research article on
A Comparison of Two Diabetic Foot Ulcer Classification Systems

THE WAGNER AND THE UNIVERSITY OF TEXAS WOUND CLASSIFICATION SYSTEMS

Abstract

OBJECTIVE— In this study, the following two ulcer classification systems were applied to new foot ulcers to compare them as predictors of outcome: the Wagner (grade) and the University of Texas (UT) (grade and stage) wound classification systems.

RESEARCH DESIGN AND METHODS— Ulcer size, appearance, clinical evidence of infection, ischemia, and neuropathy at presentation were recorded, and patients were followed up until healing or for 6 months.

RESULTS— Of 194 patients with new foot ulcers, 67.0% were neuropathic, 26.3% were neuroischemic, 1.0% were ischemic, and 5.7% had no identified underlying factors. Median (interquartile range [IQR]) ulcer size at presentation was 1.5 cm2 (0.6-4.0). Lower-limb amputations were performed for 15% of ulcers, whereas 65% healed [median (IQR) healing time 5 (3-10) weeks] and 16% were not healed at study termination; 4% of patients died. Wagner grade (P < 0.0001), and UT grade (P < 0.0001) and stage (P < 0.001) showed positive trends with increased number of amputations. For UT stage, the risk of amputation increased with infection both alone (odds ratio [OR] = 11.1, P < 0.0001) and in combination with ischemia (OR = 14.7, P < 0.0001), but not significantly with ischemia alone (OR = 4.6, P = 0.09). Healing times were not significantly different for each grade of the Wagner (P = 0.1) or the UT system (P = 0.07), but there was a significant stepwise increase in healing time with each stage of the UT system (P < 0.05), and stage predicted healing (P < 0.05).

CONCLUSIONS— Increasing stage, regardless of grade, is associated with increased risk of amputation and prolonged ulcer healing time. The UT system’s inclusion of stage makes it a better predictor of outcome.

Peripheral neuropathy is a common complication of diabetes, affecting >30% of the diabetic population (1). In the foot, peripheral neuropathy leads to dry skin and loss of the protective sensations of pressure and pain; together with reduced joint mobility (2), it also increases the risk of ulceration induced by unperceived minor injury from shoes and other physical trauma (3). The presence of macrovascular disease, possibly functional microangiopathy (4,5), and infection increases the probability of a foot ulcer leading to a lower-limb amputation (6).

Foot ulcers will occur in 5-10% of the diabetic population; up to 3% will have a lower-limb amputation (7). Ulceration is the most common precursor of amputation and has been identified as a component in more than two-thirds of lower-limb amputations (8). The presence or absence of infection and/or ischemia, footwear and pressure relief, and overall glycemic control influence the healing of ulcers (9). The depth of an ulcer is another important factor that affects the outcome of diabetic foot ulcers (10). Systematically recording these confounding factors is critical to planning treatment strategies, monitoring treatment effectiveness, predicting clinical outcomes, and improving communication among health care providers (11).

Various wound classification systems are used that attempt to encompass different characteristics of an ulcer (namely site, depth, the presence of neuropathy, infection, and ischemia, etc.) (12,13,14,15,16,17,18). It seems that poor clinical outcomes are generally associated with infection, peripheral vascular disease, and increasing wound depth; it also appears that the progressive cumulative effect of these comorbidities contributes to a greater likelihood of a diabetic foot ulcer leading to a lower-limb amputation. An easy-to-use classification system that provides a uniform description of an ulcer (including depth and presence of infection and ischemia) (19) will help in planning treatment strategies and predicting outcomes in terms of healing and lower-limb amputations.

The well-established widely used Wagner wound classification system (17) and the new University of Texas (UT) diabetic wound classification system (18) both provide descriptions of ulcers to varying degrees. Both wound classification systems are easy to use among health care providers, and both can provide a guide to planning treatment strategies.

The Wagner system assesses ulcer depth and the presence of osteomyelitis or gangrene by using the following grades: grade 0 (pre-or postulcerative lesion), grade 1 (partial/full thickness ulcer), grade 2 (probing to tendon or capsule), grade 3 (deep with osteitis), grade 4 (partial foot gangrene), and grade 5 (whole foot gangrene). The UT system assesses ulcer depth, the presence of wound infection, and the presence of clinical signs of lower-extremity ischemia. This system uses a matrix of grade on the horizontal axis and stage on the vertical axis. The grades of the UT system are as follows: grade 0 (pre-or postulcerative site that has healed), grade 1 (superficial wound not involving tendon, capsule, or bone), grade 2 (wound penetrating to tendon or capsule), and grade 3 (wound penetrating bone or joint). Within each wound grade there are four stages: clean wounds (stage A), nonischemic infected wounds (stage B), ischemic noninfected wounds (stage C), and ischemic infected wounds (stage D).

The aim of this observational study was to determine which of the two wound classification systems, the UT or the Wagner, is a better predictor of outcome.

RESEARCH DESIGN AND METHODS

Study population and procedure

Diabetic patients who presented with a new foot ulcer to two specialist diabetic foot centers (Manchester, U.K., and San Antonio, TX) between 1998 and 1999 were enrolled into this observational study.

At presentation, the site of the ulcer was noted, and a photograph was taken. After wound debridement, the area of each ulcer was measured using a wound-mapping chart (3M Health Care, Loughborough, U.K.). Each ulcer was graded using both classification systems and staged using the UT system. Ulcers were labeled infected if a purulent discharge was present with two other local signs (warmth, erythema, lymphangitis, lymphadenopathy, oedema, pain). Wound depth was evaluated using a sterile blunt probe. The ability to probe to bone (20) with the presence of local or systemic infection and suggestive radiological features provided a clinical diagnosis of osteomyelitis. The diagnosis of lower-extremity vascular insufficiency was made clinically on the basis of absence of both pedal pulses of the involved foot and/or an ankle-brachial pressure index of <0.9 (21). The presence of significant sensory neuropathy was assessed using both the Biothesiometer (Biomedical Instruments, Newbury, OH) (22), to measure vibration perception threshold (VPT) at the tip of the great toe, and the simplified Neuropathy Disability Score (1,23,24). The diagnosis of clinically significant sensory neuropathy was made if the patient’s VPT was >25 V and/or the neuropathy disability score was >6 of 10.

Patients initially were seen in the diabetic foot clinic on a weekly basis and were provided with the best possible care for their ulcers at each visit. To remove extensive callus and necrotic tissue, wound debridement was performed. After wound dressing, pressure relief was provided with either a scotchcast boot or a total contact cast. Broad spectrum antibiotics were prescribed if ulcers showed clinical signs of infection (growth factors were not used to enhance healing in this study). Patients with clinical evidence of ischemia had noninvasive ultrasound vascular studies and were seen by the vascular surgeon if necessary.

Patient follow-up was part of the normal treatment. Unhealed ulcers were followed up for a minimum period of 6 months. Once a patient’s ulcer had healed completely or a lower-limb amputation was performed, the outcome was noted and the patient was deemed to have completed the study.

Statistical analysis

A χ2 test for trend (χ2trend) was used to assess the trend association between increasing grade or stage and the prevalence of lower-extremity amputation (25,25,25a). To assess the potential association between stage and the number of amputations performed by the end of the study period, χ2 analysis with odds ratio (OR) was performed. Kaplan-Meier survival analysis was used to estimate median healing times, and a log-rank test was used to compare healing times for different levels of grade or stage. Cox regression analysis was used to assess the ability of grade and stage to predict healing within the study period (25,25,25a). The 95% CI was calculated whenever appropriate, and statistical significance was defined as a P value <0.05. Statistical analysis was performed using SPSS for Windows, version 9.0 (SPSS, Chicago).

RESULTS

A total of 194 diabetic patients with recently diagnosed diabetic foot ulcers presented at the two specialist diabetic foot centers. Table 1 shows the baseline demographic details for the group of patients and baseline characteristics of their foot ulcers at first presentation. Eleven patients had no clinical evidence of moderate or severe neuropathy or vascular ischemia; when compared with the rest of the group, they were younger (47.6 ± 10.6 vs. 57.1 ± 12.6 years, P < 0.05) and had a shorter duration of diabetes (8.0 ± 4.5 vs. 15.9 ± 10.0 years, P < 0.01). The number of new foot ulcers and lower-limb amputations in each grade of the Wagner system and each grade and stage of the UT system are shown in Table 2. The main clinical outcomes for the 194 diabetic foot ulcers are shown in Table 3. Of all patients, 15% had lower-limb amputations as a result of their nonhealing ulcers, 65% had ulcers that healed completely, 4% (seven patients) died, and the remaining 16% had ulcers that still had not healed at study termination, despite a minimum follow-up period of 6 months. The percentages of patients who had clinically infected ulcers at presentation in each of the above groups were 80, 38, 57, and 19%, respectively. The patients who died were older at presentation compared with the rest of the group (70.4 ± 17.4 vs. 56.4 ± 11.0 years, P < 0.05). The deaths were due to myocardial infarction (n = 3), stroke (n = 2), pneumonia (n = 1), and septicemia as a result of an infected foot ulcer (n = 1). For the completely healed group (65% of patients), the median time taken for ulcers to heal was 5 weeks. There were no differences in the distribution of clinical outcomes between patients who were given scotchcast boots and those given total contact foot casts for pressure relief in this study (χ2 = 0.04, P = 0.98).

See more:

http://care.diabetesjournals.org/content/24/1/84


#4

the end stage for every diabetic foot IN old age is amputation/the main problem here is peripheral ciculatotry insufficiency and immune compromisation in add to uncontrolled DM